Dondante
Bluelighter
- Joined
- Dec 6, 2005
- Messages
- 1,638
1-Naphthalen-2-yl-2-pyrrolidin-1-yl-pentan-1-one looks interesting. Might be a little too good at binding all those monoamine transporters.
Also, does it make sense to assume that the 3,4-methylenedioxy analogue (MDPV) would be similar to the 3,4-dihydroxy shown in the paper Nuke posted? Looks like a farily similar profile to methylphenidate except 5x as potent (3-5x as potent on dopamine reuptake and DAT; 6-8x as potent on norepinephrine reuptake and NET; no SERT inhibition). Makes sense from initial reports suggesting 5 mg MDPV.
It's odd that the naphthyl analogue affects SERT and serotonin reuptake so strongly when most of the others have a negligible effect. Hmmm ... how about adding that naphthyl to some phenethylamines? 1-Naphthalen-2-aminopropane? Any thoughts?
Also, does it make sense to assume that the 3,4-methylenedioxy analogue (MDPV) would be similar to the 3,4-dihydroxy shown in the paper Nuke posted? Looks like a farily similar profile to methylphenidate except 5x as potent (3-5x as potent on dopamine reuptake and DAT; 6-8x as potent on norepinephrine reuptake and NET; no SERT inhibition). Makes sense from initial reports suggesting 5 mg MDPV.
It's odd that the naphthyl analogue affects SERT and serotonin reuptake so strongly when most of the others have a negligible effect. Hmmm ... how about adding that naphthyl to some phenethylamines? 1-Naphthalen-2-aminopropane? Any thoughts?
Last edited: